← Related articles What the Newest Research Really Says About HMB and Muscle Preservation

What the Newest Research Really Says About HMB and Muscle Preservation

Updated: July 30, 2026
🔊 Listen to this article

Beta-hydroxy beta-methylbutyrate, better known as HMB, has been marketed for two decades as an "anti-catabolic" supplement that helps preserve muscle mass and strength — especially for older adults and anyone cutting calories. A large new meta-analysis published in Age and Ageing in March 2026 puts that reputation to a serious test, and the results are more mixed than most supplement marketing suggests.

What the newest evidence found

The meta-analysis pooled 13 randomized controlled trials totaling 561 participants aged 50 and older, all comparing HMB supplementation plus resistance training against resistance training alone (or with placebo). The researchers found no statistically meaningful difference between groups on any of the three main outcomes: fat mass (standardized mean difference, SMD = 0.24, 95% CI: −0.01 to 0.49), lean muscle mass (SMD = 0.05, 95% CI: −0.10 to 0.20), or muscle strength (SMD = 0.04, 95% CI: −0.72 to 0.63). All three confidence intervals crossed zero, meaning the true effect could just as easily be negligible or nonexistent. The authors concluded plainly: "HMB supplementation cannot be recommended as a routine adjunct to resistance training in individuals who are able to undertake structured exercise."

Why the picture is more nuanced than "HMB doesn't work"

That conclusion applies specifically to healthy, exercising older adults already doing resistance training — not to every scenario where HMB has been studied. A separate 2025 systematic review of surgical patients found HMB supplementation was associated with better mid-arm muscle circumference, greater appendicular skeletal muscle mass, and longer 6-minute walking distances compared with controls, along with shorter hospital stays in some trials. And a 2025 preclinical study in Biogerontology showed that HMB (340 mg/kg/day in animal models) reduced markers of muscle breakdown (MAFbx and MuRF1) and helped preserve strength during forced inactivity and protein deprivation — conditions that resemble bed rest, illness, or aggressive dieting more than a structured gym program.

Where HMB still shows the most promise

Typical dosing used in research

Most clinical trials, including the ones reviewed above, use approximately 3 g of calcium HMB (CaHMB) per day, commonly split into three 1 g doses taken with meals. This is the dose most consistently studied for safety and is the one referenced in most sports-nutrition literature — but it is worth noting that this same dose is exactly what failed to move the needle in the new meta-analysis of trained older adults, underscoring that more HMB is not automatically better.

Practical takeaways

The bottom line

HMB is not a wasted supplement, but it is also not the guaranteed muscle-preservation tool it is sometimes marketed as. For healthy, already-training older adults, the newest large meta-analysis found essentially no added benefit over resistance training alone. Its strongest evidence base remains in contexts of inactivity, illness, surgery, or steep calorie restriction — situations where muscle loss risk is highest and any anti-catabolic support has more room to matter.

Helpful products

  • HMB (calcium HMB) supplement — the form and dose (around 3 g/day) most commonly used in clinical research.
  • Whey protein powder — a practical way to help meet the higher daily protein targets linked to muscle preservation during calorie restriction.
  • Creatine monohydrate — studied alongside HMB in older adults for functional strength support.
As an Amazon Associate we earn from qualifying purchases.

Sources: Efficacy of HMB supplementation as an adjunct to resistance training in older adults: a comprehensive meta-analysis — Age and Ageing, March 2026; HMB supplementation in surgical patients — systematic review and meta-analysis, 2025; HMB supplementation mitigates muscle atrophy induced by inactivity and protein deprivation — Biogerontology, 2025.

Source: Age and Ageing (Oxford Academic), March 2026